Harbour Investments, Inc. Grifols Sa Transaction History

Harbour Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.14 - $9.29 $385 - $501	54 New	54 $0
Q2 2022 Aug 15, 2022	BUY	$10.6 - $13.28 $2,088 - $2,616	197 New	197 $2,000
Q4 2021 Feb 16, 2022	SELL	$10.21 - $15.27 $17,602 - $26,325	-1,724 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.07 - $17.3 $3,193 - $3,927	227 Added 15.16%	1,724 $25,000
Q2 2021 Aug 16, 2021	BUY	$16.62 - $18.94 $7,695 - $8,769	463 Added 44.78%	1,497 $26,000
Q1 2021 Aug 17, 2021	BUY	$15.15 - $19.78 $15,089 - $19,700	996 Added 2621.05%	1,034 $18,000
Q1 2021 May 12, 2021	BUY	$15.15 - $19.78 $575 - $751	38 New	38 $1,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.